TuesdayApr 15, 2008 7:49 am

StockGuru Stocks to Watch for Tuesday, April 15, 2008 Featuring Metro One Development, NextGen Bioscience, China Voice, Sports Pouch Beverage and KCM Holdings

Metro One Development, Inc. (OTCBB: MODI) Metro One Development, Inc. (OTCBB: MODI) - Monday’s shares increased 0.05% to $0.20. 7,768 shares were traded. Metro One Development, Inc., a custom builder and property developer in the Greater Toronto Area (’GTA’), Canada, announced today a shareholder update from President and CEO Mr. Stuart Turk.”On behalf of the Metro One Development Management team and Board of Directors, I’m proud to announce that, after a busy month following the sale of our VAR business, we have set the foundation to commence delivering on our business plan as a custom builder and property developer specialist…

Continue Reading

TuesdayApr 15, 2008 7:48 am

StockGuru News: China Voice Holding (CHVC) Hires Key Executive

StockTalkJournal: Who is China Voice? Focus Will be Increasing Margins and Expanding Wholesale Termination Operations BOCA RATON, Fla.–China Voice Holding Corporation, announced today that it has hired James Rapant as Vice President of Business Development for its wholly owned U.S. subsidiary, CVC International, Inc. (CVC). Mr. Rapant will focus on maximizing the profitability of the Company’s new Prepaid Calling Card products and broadening the base of Suppliers for its wholesale termination business. CHVC’s President and CEO Bill Burbank said, “James brings over 16 years of Sales and Business Development experience to the Company. He has vast experience in working with…

Continue Reading

TuesdayApr 15, 2008 7:46 am

StockGuru Trade Alert: Profile Stock Lotus Pharmaceuticals (LTUS) Up Over 33% Intraday on Volume More than 4 Times Ten-Day Average

StockGuru Trade Alert: Profile Stock Lotus Pharmaceuticals (LTUS) Up Over 33% Intraday on Volume More than 4 Times Ten-Day Average Ten-Day Average Volume: 32,600 Today’s Volume: 151,595 Intraday High Price is $0.95 Compared to Yesterday’s Close of $0.71 View the StockGuru Profile for LTUS: http://stockguru.com/profiles/ltus

Continue Reading

TuesdayApr 15, 2008 7:20 am

Smoky Market Foods Inc. (SMKY.OB) Providing Great Tasting Foods to your Table Straight from the Heart of the Midwest!

Smoky Market Foods Inc. has come a long way since founder and CEO Edward Feintech opened his first barbeque restaurant in Des Moines, Iowa in 1977. More than thirty years of trials and tribulations have taught Eddie to be a true artist at his craft. Smoky Market Foods still uses the same wood-burning oven techniques to create an authentic, hickory-roasted flavor in fresh meats and fish - a technique that has put their name on the map - but now the process is accomplished using economies of scale that allow Smoky Market Foods to efficiently produce up to 15,000 pounds…

Continue Reading

TuesdayApr 15, 2008 5:43 am

Fund.com, Inc. (FNDM.OB) – Leaving its Footprint in the $10.6 Trillion Mutual Fund Industry

The Internet has created a demand for convenience and ease in every aspect of our lives, from shopping and banking to research and trading. Vertical marketplaces provide consumers with that desired ease, delivering a wealth of information for a specific niche to consumers wanting higher quality leads and advertising opportunities. Fund.com (OTCBB: FNDM) is a vertical marketplace centering on the large fund industry, delivering a combination of fund-related content, aimed at presenting unbiased, relevant and in-depth information to the $10.6 trillion mutual fund industry. “By focusing on funds with Fund.com we believe we will have an advantage over general financial…

Continue Reading

TuesdayApr 15, 2008 5:36 am

Peregrine Pharmaceuticals, Inc. (PPHM) Studies Indicate New Therapy Reduces Tumors Up to 95% and Reduces the Metastatic Spread of Tumor Cells

Peregrine Pharmaceuticals, Inc. (Nasdaq: PPHM) announced this morning preclinical data presented at the 2008 Annual Meeting of the American Association for Cancer Research (AACR). The data shows that a mouse equivalent of Peregrine's anti-phosphatidylserine (anti-PS) vascular targeting antibody bavituximab administered in combination with the chemotherapeutic agent docetaxel demonstrated excellent signs of efficacy in a preclinical model of hormone-refractory prostate cancer. This new data confirms and extends the results of previous studies of Peregrine's anti-PS antibodies in models of prostate cancer. Specifically, in the study 2aG4 administered with docetaxel reduced primary tumor burden by 95%, an anti-tumor effect that was significantly…

Continue Reading

Market Basics

New to the micro-cap markets?Get answers to your questions about investing in Small-Cap / Micro-Cap Stocks and learn how to protect yourself.

The Basics

Newsletter Publishers

Have an up and coming newsletter and want to be included in our coverage list? Looking to get more coverage and grow subscriptions? Register for coverage.

Register

Public Companies

Are you a Small-Cap / Micro-Cap company looking for coverage? We'd love to hear from you. Fill out our quick contact form or send us a text.

Get Covered